Role of L-Selectin Gene P213S Polymorphism and Macrophage Profiles (M1, M2) in Cases of Endometriosis by Siregar, Henry Salim
Journal of Biology, Agriculture and Healthcare                                                                                                                                www.iiste.org 
ISSN 2224-3208 (Paper)  ISSN 2225-093X (Online) 
Vol.4, No.16, 2014 
 
107 
Role of L-Selectin Gene P213S Polymorphism and Macrophage 
Profiles (M1, M2) in Cases of Endometriosis 
 
Henry Salim Siregar (Corresponding author) 
Division of Reproductive Endocrinology and Fertility Medicine 
Department of Obstetrics and Gynecology, Faculty of Medicine, University Sumatera Utara 
H. Adam Malik Hospital, Jl. Bunga Lau 17, Medan, 20136, Sumatera Utara, Indonesia 
*E-mail: henry_siregar@yahoo.com 
 
Abstract      : 
Objective: To determine the presence of an L-selectin gene P213S polymorphism in association with the 
pathogenesis of endometriosis.Design : Comparative analytical study using a 2 population case-control 
design.Setting : Department of Obstetrics and Gynaecology at Haji Adam Malik General Hospital, Dr. 
Pirngadi Medan Hospital, networking hospitals and private clinics throughout Medan from Januray 2013 - 
March 2014. Population: Reproductive aged women complaining menstrual pain, abdominal located bulging, 
and/or infertility. Through consecutive sampling, patients suspected with endometriosis and meeting the 
inclusion criteria were taken as samples. The case group comprised of women diagnosed with endometriosis 
whereas the control group consisted of non endometriosis women.Methods : Visiting gynecology outpatient 
clinic patients were taken a complete history, and underwent physical/gynecological, sonographic examinations 
to determine an indication to perform a laparoscopy/laparotomy and, if present, a laparoscopy was scheduled to 
take place during the proliferation phase. Presence of endometriosis was assessed during the procedure, and 
further confirmed by histopathologically reviewing peritoneal specimens. Patients diagnosed with endometriosis 
were categorized into the case group, after which severity degrees were determined based on the Revised 
Classification of the American Sociey for Reproductive Medicine 1997. Non endometriosis patients were 
categorized into the control group based on inclusion and exclusion criterias. Peritoneal tissues were sampled 
and 5 cc of blood taken. DNA isolation and genotyping was then performed, whereas peritoneal tissue samples 
were histopatahologically and immunohistochemically examined. Data were univariately and bivariately 
analyzed. Descriptive data was univariately analyzed.Main Outcome Measures : CD68, CD 163, M1 and 
M2.Results  : S allele subjects had a 2,893 (95% CI; 1,135-7,373) higher risk of developing endometriosis 
than P allele subjects (p<0,05). PS and SS genotyped subjects had a 3,556 higher risk of devolping endometriosis 
than their PP genotyped counterparts (95% CI; 1,049-12,052, p-value 0,041). CD163 was more frequently 
expressed than CD68 in endometriosis lesions (60,870 ±28,939 vs 34,783 ±18,194, p-value 0,0001). Positive 
immunohistochemical scorings revealed CD68 macrophages were less frequently expressed (69,96%) than 
CD163 macrophages (100%) (p-value 0,0001).Conclusion  : L-selectin gene P213S polymorphism is 
associated with endometriosis. M2 Macrophage has a more significant role in developing endometriosis than M1 
macrophage.   
 
INTRODUCTION 
Endometriosis is a benign disease defined as an extra uterine presence of endometrial glands and stromas, and is 
associated with pelvic pain and infertility. Clinical manifestations are usually broad spectrum and highly 
progressive and with high recurrence rates, and frequently cause treatment complicating issues for both patients 
and clinicians.
1
 10% of reproductive aged women, of all ethnic and social groups, are diagnosed with this 
disease.
2
 Approximately 20-40% infertile women are diagnosed with endometriosis.
3,4
   
Endometriosis causes serious physical, mental, and social implications
5,6
 and is also an economic burden to the 
society. Simoens et al estimated a US national cost of approximately 22 billion USD in 2002.
7
 Hummelshoj et al 
reported that 78% of women diagnosed with endometriosis in UK lost an average of 5,3 working days due to this 
disease.
8
 
However, the pathogenesis is not fully understood.
9
 A theory by Sampson in the mid 20s was unable to explain 
as to why endometriosis only occurs on a few amount of women. Most women experience retrograde 
menstruation (76-90%) that flows into the peritoneal cavity, however, endometriosis is only evident in 5-10% of 
these cases.
10
 Therefore, endometriosis may not only involve retrograde menstruation but also other factors on 
the molecular level, including genetic defects and immune system or both, eg. endometrial cell adhesion and 
invasion, proliferation, angiogenesis, and immune system dettachment.
11
 
Endometriosis has several genetic predispositions.
1
 Several data indicate that endometriosis is associated with 
subclinical peritoneal inflammation characterized by increased peritoneal volume, peritoneal white blood cell 
concentration (especially increased macrophage activities), and increased inflammatory cytokines, growth 
factors, and angiogenic supporting substances.
12
  
Due to potencial T cell regulatory changes, T cells, B cells, mast and dendritic cell and macrophages are altered, 
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from which ectopic lesions may occur, affecting the events of endometriosis and it’s progresivisity.
13
 Several 
studies have shown altered immune cell function in endometriosis women, indicated by decreased cytoyoxic T 
cell and Natural killer cell activities, cytokine secretion by T cell helpers, and autoantibody production by 
lymphocyte B.
 14
    
Macrophages are normally located in the peritoneum, the amount and activities of which are markedly increased 
in endometriosis women.
1
 Study on rats indicate that alternatively activated macophages (M2) dramatically 
increase growth of endometriosis lesions, whereas inflammatory macrophages (M1) effectively protect them 
from endometriosis.
15
  
L-selectin functions in the initital recruitment of circulating leucocytes in to peripheral inflammatory sites, 
known as rolling leucocytes followed by activation, marked adhesion, and leucocyte transmigration to interstitial 
tissues.
16
  
A immunohistochemical study comparing L-selectin locations in rat model endometriosis tissues and human 
counterparts revealed that L-selectin was more dominantly expressed in interstitial spaces, including 
macrophages and lymphocytes compared to endometriosis epithelium, and concluded that L-selectin plays a 
significant role in the pathogenesis of endometriosis.
17
 
No study has previously assessed the association between L-selectin gene Polymorphism with endometriosis. 
This study was therefore conducted to assess the association between P213S polymorphism with events of 
endometriosis, and to observe the role of alternatively activated macrophages (M2) compared to scavenger 
macrophages (M1) in the pathogenesis of this disease. 
 
METHODS 
This comparative analytical, two population case-control study was approved by the health research ethical 
committee of North Sumatera c/o Medical School, Universitas Sumatera Utara and was conducted at the 
Department of Obstetrics and Gynecolocy at Haji Adam Malik General Hospital, Dr. Pirngadi Medan Hospital, 
Networking hospitals and private clinics throughout Medan from January 2013 - March 2014 until the minimum 
required amount of samples was obtained. Reproductive aged women, complaining menstrual pain, abdominal 
located bulging, and/or infertility, visiting the Gynecology outpatient clinics at Haji Adam Malik General 
Hospital, Dr. Pirngadi Medan Hospital, satellite hospitals and private hospitals throughout Medan, comprised the 
study population, from which patients suspected with endometriosis based on a history taking, physical and 
sonographic examination and meeting the inclusion criteria were taken as samples through consecutive sampling. 
Sample size was statistically determined (α = 0,05  Zα=1,96 dan β = 0,20  Zβ=0,84), from which the case 
and control group were both allocated with 22 samples each. The case group comprised of women diagnosed 
with endometriosis whereas the control group consisted of non endometriosis women.  
This study aimed on determining an association betweeen L–selectin gene P213S polymorphism with cases of 
endometriosis, using M1 and M2 macrophage profiles/ratios as intermediating variables between the two. 
Previous studies showed that potentially disrupting factors include history of ischemic stroke, spinal muscular 
atrophy, and celiac disease and were consequently considered exclusion criterias. 
Two hypotheseses were proposed. The first, L–selectin gene P213S polymorphism was hypothesized to be 
associated with the events of endometriosis, whereas the second was to propose a role discrepancy between M1 
and M2 macrophages in the pathogenesis of endometriosis. 
Twenty to 45 year old women, laparascopicsally/laparatomically and histopatahologically confirmed diagnosed 
with endometriosis, with irregular menstrual cycles and also willing to participate after filling a written informed 
consent form, were included in the case group. Twenty to 45 year old women, laparascopicsally/laparatomically 
and histopatahologically confirmed not diagnosed with endometriosis, eg., cases of self requested tubectomy, 
regular menstrual cycles, and also willing to participate after filling a written informed consent form were 
assigned to the control group.    
Gynecological disorders, including non endometriosis ovarian cyst, ovarian tumor, and uterine myomas, 
endocrine disorders, currently on hormonal medication for minimally 3 months prior to recruitment, with a 
previous pelvic surgery, history ischemic stroke, muscular spinal atrophy, and Celiac disease, or patients who 
self withdrew, were excluded from the study. 
Visiting patients at the gynecology outpatient clinic were taken a complete history, and then underwent 
physical/gynecological and sonographic examinations to determine an indication (including history of infertility, 
dysmenorrhea, self requested tubectomy, endometriosis cyst, etc) to perform a laparoscopy/laparotomy, and if 
present, a laparoscopy was scheduled to take place during the menstrual cycle of the proliferation phase. 
The presence of endometriosis was assessed during laparoscopy/laparotomy and was further confirmed by 
histopathologically examining peritoneal tissues. Laparoscopy is an endoscopic procedure that directly visualizes 
the peritoneal cavity using a small telescope. Endometriosis was defined as an extra uterine ectopic endometrial 
glands or stromas, the presence of which were confirmed laparascopically or histopathologically. Patients 
diagnosed with endometriosis were included in the case group, after which severity was assessed based on the 
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Revised Classification of Endometriosis, American Society For reproductive Medicine (ASRM), 1997 (see fig. 
1), which is as follows : stage I (minimal degree) : ASRM score 1-5, stage II (mild degree) : ASRM score 6-15, 
stage III (moderate degree) : ASRM score 16-40, and stage IV (severe degree) : ASRM score >40.    
Non endometriosis patients were categorized in to the control group based on inclusion and exclusion criterias. 
During the procedure (laparoscopy/laparotomy), peritoneal tissues were sampled and 5 cc blood taken by venous 
punctures from the ante cubiti vein area. DNA isolation and genotyping was performed on these samples, 
whereas peritoneal tissue samples were histopathologically and immunohistochemically examined by semi-
quantitative percentage of cells (Score 0: 0%; 1: 1-25%; 2: 26-50%; 3: 51-75%; 4: >75%). 
Histopathological dan Imunohistochemical Examination of Peritoneal Tissues  
Peritoneal tissue samples were examined at the Pathology laboratory, Medical Faculty, University of Sumatera. 
During the procedure, peritoneal tissues of endometriosis and non endometriosis samples were biopsied and 
fixated using 10% buffer formalin. Fixated tissues were dehydrated by alcohol for 1 hour and 30 minutes, and 
then cleared using xylene, from which paraffin block were made. These blocks were then cut into 4 µm thick 
pieces, inserted into a water bath, and subsequently placed on a previously glycerine spreaded object glass. 
Specimens were then defarafinized using xylol, rehydrated with alcohol, rinsed with streaming water, and 
stained using Haemotoxyline-Eosine. These specimens were histopatahologically examined under a light 
microscope with a 400 time magnification, immunohistochemically proccessed using monoclonal mouse anti-
human-CD68 (Clone PG-M1) and anti-CD163 (Dako) (BD Pharmingen) staining, and then rinsed using Tris 
Buffered saline (TBS) pH 7,4. DAB was then combined with a chromogene solution and was diluted with the 
following ratio : 20 µL DAB : 1000 µL substrate. On cleaning with streaming water, specimens were 
counterstained using haematoxylin and 5% lithium carbonate, and cleaned again with streaming water, after 
which samples were dehydrated with alcohol and cleared with xylol. Samples were then microscopically 
examined. Immunoprecipitated areas of M1 and M2 macrophage cells [with anti-human-CD68 mouse 
monoclonal markers (Clone PG-M1) and anti-CD163 presented peritoneal tissue slices] were calculated in 
antigen percentages. 
Macrophage (M0) is defined as a monocyte originated macrophage. Main types include: peritoneal and alveolar 
macrophages; hystiocytes; liver Kupffer cells, and osteoclasts. These macrophages function in non specific 
(innate) and specific (cell-mediated) immunity systems and by fagositizing cellular and pathogen debris, acting 
as both a stationary or mobile cell, and also stimulating lymphocytes and other immune cells to respond against 
pathogens. M1 macrophage is a macrophage induced by the classical profile activation triggered by microbial 
products, including LPS or TH1 cytokines (IFN--γ and TNF-α). M1 macrophage synthesizes and releases pro-
inflammatory factors, including IL-1β, IL-6, IL-12, and TNF-α, producing high concentrated NO and reactive 
oxygen intermediates (ROIs), and type-1 chemochins, such as CXCL-10, CXCL-11, and CCL5. M1 
macrophages are associated with microbial activities, tumor resistance, and cytotoxic tissue damage.   
Under stimulation by specific cytokines, eg. IL-4, IL-10, IL-13, and non GM-CSF M-CSF, LPS, INF, etc, M2 
macrophages alter the inflammatory and adaptive immune proccess, thus promoting cell proliferation by 
producing growth factors and arginase pathway products, engulf debris by expressing scavenger receptors, and 
support angiogenesis, tissue remodelling and regeneration, suppress the adaptive immunity system and support 
endomteriosis growth. CD-163 is a Hemoglobin/haptoglobin complex scavenger receptor, expressed dominantly 
by M2 macrophages. CD-68 (Clone PG-M1): M1 macrophage surface marker. 
DNA Isolation 
During laparoscopy, 500 µL peripheral blood samples were taken from case and control groups by venous 
punctures from the antecubiti vein, from which DNA was extracted and analyzed. Genom DNA was extracted 
using a High Pure PCR Templete Preparation Kit (Roche Applied Biosystem). and then restored using an EDTA 
anticoagulant at 4°C, until used for analysis. 
DNA is a polimere of deoxyrybonucletide units. A nucleotide consists of a nitrogen base, one glucose and one 
more phosphate sequences. The genome is defined as the most comprehensive complement of human DNA.    
Genotyping 
L-selectin gene P213S polymorphism genotyping was examined using the PCR-RFLP method. PCR is a 
technique used to amplify small fragments or DNA areas into sufficiently larger particles adequate for analysis, 
using electrophoresis and blotting. These fragments were amplified in a Perkin Elmer Gene Amp PCR system 
2400, in 25 µL reaction volumes containing 200 ng genome DNA, 200 µM for every dATP, dCTP, dGTP, dTTP, 
50 mM KCl, 10 mM Tris-HCl, 3mM MgCl2, 0,5 µM from each primary, and 1 unit Taq polimerase (FastStart 
Taq DNA Polymerase, dNTPPack, Roche Applied Biosystem). The primary sequence was as follows: forward 
5’-TGATTCAGTGTGAGCCTTTG-3’ and reverse 5’-CTTGACAGGTTGGTTCTG-3’. The PCR reaction was 
performed in the following condition: 2 minutes at 94°C, 30 cycles for 1 minute at 94°C, 50 seconds at 59°C, 40 
seconds at 72°C and 1 minute at 72°C. 
Gen polymorphism was defined as inter various gene DNA sequences between individuals, groups, or 
populations. L-selectin gene P213S polymorphism gene is an L-selectin gene polymorphism, in which the 
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cytokine base is converted into thymin on codon number 213, causing the conversion of proline (P) into Serine 
(S). 
PCR products (length 186 base pairs) were verified using agarosa gel electrophoresis (2%) and then digested for 
3 hours using a 5 5 U/reaction Hph I enzyme (New England Biolabs, Inc. Beverly, USA), according to 
manufacturer instructions. On ethidium bromida staining, restricted products were visualized on the 8% 
polyacrilamide gel under ultraviolet light. DNA were isolated and genotyped at the Medan Prodia Laboratory in 
cooperation with the Eijkman Molecular Biology Institute, Jakarta. 
Data were univariately and bivariately analyzed. Descriptive data were univariatelt analyzed. Using bivariate 
analysis, variables were analyzed using a chi-square test (a p value<0,05 was considered statistically significant) 
to compare genotype distribution of polymorphism and macrophage profiles between case and control groups.  
 
RESULTS           
On histopatahologically confirming endometriosis in patients who previously underwent laparotomy/laparoscopy 
at Haji Adam Malik General Hospital, Permata Bunda Hospital, and Stella Maris Hospital from Januray 2013-
March 2014, 23 subjects were enrolled and assigned to the case group. Whereas, 23 non endometriosis subjects, 
previously undergoing a laparoscopic tubectomy at the Mantap Sterilisation Clinic, Medan and confirmed with 
no peritoneal or reproductive organ lesions of endometriosis, were assigned to the control group. Blood samples 
were taken preoperatively and only non endometriosis tissues were histopatahologically and 
immunohistochemically examined. 
Subjects Demographic Characteristics 
Demographic characteristics are shown in table 1. Endometriosis and non endometriosis subjects were averagely 
aged 32,83 and 35,48 years old, respectively. The case group was dominated by stage 4 endometriosis patients 
(69,9%). No cases of stage endometriosis were encountered. Ethnicity was diversed as subjects came from 
various areas.  
Table 1. Subject Demographic Charecteristics 
Charecteristics Endometriosis Non Endometriosis 
Age, Mean (±SD) 32,83 (±6,827) 35,48 (±5,877) 
Ethnic, n (%) 
Acehnese 
Bataknese 
Javanese 
Indian 
Malay 
Nias 
Tionghoa 
Minang 
 
2 (8,7) 
9 (39,1) 
8 (34,8) 
1 (4,3) 
1 (4,3) 
1 (4,3) 
1 (4,3) 
- 
 
2 (8,7) 
5 (21,7) 
11 (47,8) 
- 
2 (8,7) 
1 (4,3) 
- 
2 (8,7) 
Endometriosis Stage, n (%) 
Stage 1 
Stage 2 
Stage 3 
Stage 4 
 
- 
2 (8,7) 
5 (21,7) 
16 (69,6) 
 
- 
- 
- 
- 
Distribution and Association between Genotype and P213S L-selectin allele  
Table 2 displays genotype frequency rates of L-selectin gene P213S polymorphism in endometriosis and non-
endometriosis subjects. 30,4%, 56,5%, and 13% endometriosis subjects had a PP, PS, and SS genotype, 
respectively whereas 60,9%, 39,1%, and 0% non-endometriosis subjects had a PP, PS, and SS L-selectin gene 
P213S polymorphism genotype, respectively. Chi-square tests showed that genotyping significantly differed 
between endometriosis and non endometriosis subjects, with a p value of 0,048. 
Tabel 2. Association between genotype and cases of endometriosis 
Genotypes 
Subjects 
p* 
Endometriosis Non Endometriosis 
PP 7 (30,4%) 14 (60,9%) 
0,048 
PS 13 (56,5%) 9 (39,1%) 
SS 3 (13%) 0 (0%)  
Total 23 (100%) 23 (100%)  
  *Chi-square test 
This study focused on the P and S allele (of L-selectin gene P213S polymorphismgene) and the possible 
associated role in developing endometriosis, assuming that the P coversion to S would increase incidence rates of 
this disease. Results from table 3 show that the S allele has higher frequency rates in endometriosis subjects than 
non endometriosis subjects (41,3% vs 19,6%). The P and S allele were correlated with the diagnosis of 
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endometriosis, with correlation coefficients of 0,363 (pvalue 0,48) and 0,383 (p value 0,034), respectively. 
Table 3. Association between L-selectin P213S allele and endometriosis 
Allele 
Subjects 
R p* 
Endometriosis Non Endometriosis 
P 27 (58,7%) 37 (80,4%) 0,363 0,048 
S 19 (41,3%) 9 (19,6%) 0,383 0,034 
Total 46 (100%) 46 (100%)   
     *Chi-square test 
Assuming that the S allele is associated with increased rates of endometriosis, table 4 shows that S containing 
genotypes (PS and SS genotype) are more frequently encountered in the case groups than the control group 
(69,6% vs 39,1%). This fact also applies for endometriosis subjects, with higher incidence rates of S containing 
genotypes (PS and SS, 696%), than the P containing type (30,4%). Increased S allele containing genotype rates 
(PS and SS) in cases of L-selectin P213S gene polymorphism was significantly associated with events of 
endometriosis (p = 0,038). 
Table 4. Association between PP and PS+SS L-selectin gene P213S polymorphism genotypes and endometriosis 
Genotypes 
Subjects 
p* 
Endometriosis Non Endometriosis 
PP 7 (30,4%) 14 (60,9%) 
0,038 
PS + SS 16 (69,6%) 9 (39,1%) 
Total 23 (100%) 23 (100%)  
  *Chi-square test 
Table 5 displays the extent of association between S alleles and events of endometriosis, from which the 
presence of this allele is associated with a 3 times higher risk of developing endometriosis (OR 2,893; IK 95% 
1,135 - 7,373, p value 0,026). The results of this table also show that S allele carrier containing genotypes (SS 
and PS) have a 4 times higher risk than the PP genotype (OR 3,556; IK 95% 1,049 - 12,052, p value 0,04).Table 
6 shows that PP, PS, and SS containing genotypes were dominantly staged 4 (37,5%, 43,8%, and 18,8% 
respectively), whereas all SS genotyped subjects had stage 4. Only 5 PS genotyped subjects had stage 3, whereas 
one PP and PS genotyped subject each were staged 2. On classifying endometriosis into two groups, minimal-
mild and moderate-severe, no significant association was apparently established between severity degrees and 
P213S L-selectin gene genotypes, the results of which are displayed in table 7 (p value 1,0). 
Table 5. Association between S allele and L-selectin gentype with cases of endometriosis 
Subjects p* OR* IK 95% 
S Allele 0,026 2,893 1,135 – 7,373 
PS + SS Genotype 0,041 3,556 1,049 – 12,052 
  *Mantel-Haenszel Common Odds Ratio Estimate 
 
Table 6. Distribution of endometriosis stages based on L-selectin P213S genotypes 
Subjects 
Genotype 
PP PS SS 
Stage 2 1 (50%) 1 (50%) 0 (0%) 
Stage 3 0 (0%) 5 (100%) 0 (0%) 
Stage 4 6 (37,5%) 7 (43,8%) 3 (18,8%) 
      *Kolmogorov-Smirnov Z test 
 
Table 7. Association between severity degrees of endometriosis and L-selectin P213s genotypes 
Severity degrees of 
Endometriosis 
Genotype 
p* 
PP PS SS 
Minimal – Mild  1 (50%) 1 (50%) 0 (0%) 1,0 
Moderate – Severe  6 (28,6%) 12 (51,7%) 3 (14,3%)  
Distribution and Association Between Macrophages and Endometriosis 
Specimens were blindly immunohistochemically examined by two pathologists, from whom the clinical features 
of each group were with held. Table 8 shows kappa values of 92,6% and 100% for CD68 and CD163, 
respectively, indicating a high inter observer uniformity in assessing CD68 and CD 163 expression.  
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Table 8. Kappa value to Observer 1 and Observer 2 
Observer Compatibility  Value p value 
CD68  0,926 0,0001 
CD163 1,000 0,0001 
Semi-quantitative immunohistochemical scoring shows that 21,72%, 26,1%, and 21,7% endometriosis subjects 
express CD68 +1, +2, and +3 macrophages, respectively (overall 69,6% expressed CD68), with a remaining 
30,4% non CD68 expressing subjects, with eta coefficient was 0,647 (table 9). Only 8,7% of non endometriosis 
subjects expressed CD68 macrophage, with a IHC score of +1. Contradictively, all endometriosis subjects 
expressed CD163 macrophages, with the following incidence rates: 21,7%, 30,4%, and 47,8% subjects 
expressing +1, +2, and +3 CD 163 macrophages, respectively, the results of which are displayed in table 10. 
Whereas only 8,7% of non endometriosis subjects expressed CD163 macrophages. 
Table 9. Association between CD68 macrophage expression and endometriosis 
 
IHC SCORE 
r* p** 
0 +1 +2 +3 
Endometriosis 7 (30,4%) 5 (21,7%) 6 (26,1%) 5 (21,7%) 0,647 0,001 
Non endometriosis 21 (91,3%) 2 (8,7%) 0 (0%) 0 (0%)  
 
 *Eta Correlation, **Chi-square test 
Table 10. Association between CD163 macrophage expression and endometriosis 
       
IHC SCORE 
r* p** 
0 +1 +2 +3 
Endometriosis 0 (0%) 5 (21,7%) 7 (30,4%) 11 (47,8%) 0,936 0,001 
Non endometriosis 21 (91,3%) 2 (8,7%) 0 (0%) 0 (0%)  
 
 *Eta Correlation, **Chi-square test 
Results from table 11 shows that macrophages from CD68 expressing endometriosis lesions significantly differ 
to their counterparts from CD163 expressing lesions, with positive CD68 and CD163 cell expressions of 34,783 
±28,939 and 60,870 ±18,194, respectively (p<0,0001). Alternatively, activated CD163 macrophages were more 
frequently encountered than CD68 counterparts Immunohistochemical testing reported that CD68 and CD163 
macrophages infiltrate endometriosis lesions, although non endometriosis specimens also revealed similar 
findings. 
Table 11. Macrophage positive cell percentages: a comparison in endometriosis 
Marker Mean Positive cells (±SD) CI 95% p* 
CD68 34,783 (±28,939) 22,27 – 47,30 0,001 
CD163 60,870 (±18,194) 53,00 – 68,74  
  *Independent sample t-test 
Results from table 12 show that CD68 expression did not significantly differ between degrees of severity (p-
value 0,995). Expression of lesion infiltrating macrophages did not differ in moderate-severe cases, with 28,6%, 
23,8%, 28,6% and 19% endometriosis subjects expressing CD68 IHC scores of 0, +1, +2, and +3, respectively. 
Mild-minimal degree subjects also showed a similar tendency. Although expression rates was increased in 
moderate-severe cases (23,8%, 28,6%, and 47,6% subjects expressed +1, +2 and +3 CD163), CD163 expression 
also did not significantly differ between degrees of endometriosis, as shown by results displayed in table 13 (p-
value 1,0). 
Table 12. Association between severity degrees of endometriosis and CD68 expression 
Severity degrees of 
Endometriosis 
Immunohistochemical scoring of CD68 
p* 
0 +1 +2 +3 
Minimal – Mild  1 (50%) 0 (0%) 0 (0%) 1 (50%) 0,995 
Moderate – Severe  6 (28,6%) 5 (23,8%) 6 (28,6%) 4 (19%)  
  *Kolmogorov-Smirnov Z test 
Table 13. Associaton between severity degrees of endometriosis expression of CD163 
Severity degrees of 
Endometriosis 
Immunohistochemical scoring of CD163 
p* 
+1 +2 +3 
Minimal – Mild  0 (0%) 1 (50%) 1 (50%) 1,0 
Moderate – Severe  5 (23,8%) 6 (28,6%) 10 (47,6%)  
  *Kolmogorov-Smirnov Z test 
Table 14 displays that S allele containing (PS and SS) genotypes was encountered in 68% of CD163 macrophage 
expressing specimens, indicating that CD163 expression (M2) was significantly associated with certain 
genotypes (p-value 0,043). 
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Table 14. Association between L-selectin gene P213S polymorphism genotype on expression of CD163 and 
CD68 
Genotype 
Expression of CD163 
p* 
Expression of CD68 
p* Positive CD163  Negative 
CD163  
Positive CD68  Negative CD68  
PP 8 (38,1%) 13 (61,9%) 
0,043 
7 (33,3%) 14 (66,7%) 
0,46 
PS + SS 17 (68%) 8 (32%) 11 (44%) 14 (56%) 
*Chi-square test 
However, contradictive results are shown, indicating that P213S genotypes of L-selectin genes were apparently 
not significantly associated with CD68 expression. CD68 was found positive in 33,33% and 44% of PP and 
PS+SS genotypes, respectively. The expression of CD 163 is displayed in figures 8 and 9. 
Hypothesis Testing 
Hypothesis I 
Bivariate analysis shows that S allele subjects had a 2,893 (95% CI; 1,135-7,373) higher risk of developing 
endometriosis than P allele subjects, with a p value of 0,026 (p<0,05). Results also revealed that PS and SS 
genotyped subjects had a 3,556 higher risk of developing endometriosis than their PP genotyped counterparts 
(95% CI; 1,049-12, 052, with a p-value 0,041), thus indicating that L-selectin gene P213S polymorphism is 
associated with the incidence of endometriosis. 
Hypothesis II 
Analysis through differentiating average positive cells expressed from CD68 and CD163 antigenes (designated 
as M1 and M2 respectively) showed that CD163 was more frequently expressed than CD68, in endometriosis 
lesions (60,870 ±28,939 vs 34,783 ±18,194) with a p-value 0,0001. Positive immunohistochemical scorings 
revealed that CD68 macrophages was less frequently expressed (69,96%) than CD163 macrophages (100%) with 
a p-value 0,0001, indicating different roles of M1 and M2 macrophages in the pathogenesis of endometriosis.  
 
DISCUSSION 
This study showed that S allele subjects (with L-selectin gene P213S polymorphismgene) have a 3 time higher 
risk than P allele subjects to develop endometriosis (OR 2,893; 95% CI; 1,135-7,373 with a p value 0,026). 
SNP’s are various sources of a genom and is generally a mutated base form. They are the most simple and 
common form of human genetic polymorphism.
18
 As they are located on regulator elements (such as gene 
promotors, enhancers or silencers) and coding regions, synonymous SNPs, may cause amino acid alterations, 
frame shifts or terminated translations, consequently providing functional effects on protein levels.
11
 P213S 
polymorphism is itself an SNP, in which the 637
th
 base is converted (from Cytosine to Thymine on exon 6), 
resulting in amino acid coding on codon 213 (from Proline to Serine). Exon 6 located on the L-selectin gene, is 
known as the domain of the Short Consensus Repeat (SCR1), that functions in cell adhesions, oligomerization, 
optimizes Epidermal Growth Factor (EGF) and lectin domains. Consequently, exon polymorphism would effect 
L-selectin gene SCR1 associated functions.
19
 In this study, this event is stressed as mostly associated with the 
events of endometriosis.      
This study shows that PS and SS genotypes are more significantly associated with the events of endometriosis 
than PP genotyped specimens, whereas no non endometriosis subject was SS genotyped. S alleles was more 
frequently encountered in endometriosis specimens than the control group. However, this study demonstrated 
that severity degrees of endometriosis was not associated with L-selectin gene P213S polymorphism. 
Combining L-selectin with monoclonal and ligand antobodies may cause alterations in cellular morphology, 
cellular mechanical action patterns, and increase IL-9 levels and expression of TNF-α genes.
20,21
 IL-8 is 
increased in peritoneal fluids of women diagnosed with endometriosis and correlates with disease severity, and 
may act as an endometrial autocrine growth factor. Consequently, IL-8 may affect endometrial cells and cellular 
growth. TNF-α is an activated macrophage product that activates inflammatory leucocytes and is directed 
towards production of other proinflammatory cytokines, including IL-1, IL-6, and additional TNF-αs. As a result, 
endomterial cellular adhesions are stimulated, inducing MMP expression, and participates in ectopic endometrial 
tissue implantation to the peritoneum.
22
  
Odagiri et al suggested that intertitial cellular located L-selectin was expressed in human endmetriosis, including 
lymphocytes and macrophages, however, L-selectin was not expressed in epithelial L-selectins. This finding 
concluded the significant role L-selectin has in endometriosis.
17
 In a rat model, endometriois was observed with 
a 46 time mRNA transciption increase compared to normal endometrial tissues.
23
    
Peritoneal macrophage numbers and activated status are increased in women diagnosed with endometriosis. 
Increased growth factors and cytokines affect ectopic endometrial cellular survival and growth, and may cause 
receptor function disability. Activating macrophages, through cytokine and growth factor release, may contribute 
to the concurrent initial formation and development of endometriosis.
22
 Monocyte/macrophage recruitment and 
Journal of Biology, Agriculture and Healthcare                                                                                                                                www.iiste.org 
ISSN 2224-3208 (Paper)  ISSN 2225-093X (Online) 
Vol.4, No.16, 2014 
 
114 
activation induces a local inflammatory reaction and is highly affected by macrophage activating factors 
produced by both eutopic and ectopic endomterial cells, including MCP-1, migration inhibitory factor (MIF) 
macrophages, and IL-1, RANTES.
24,25,26
 
Macrophages are known to regulate antitumor immunity response. In the presence of stromal remodelling 
related-tumor growth factors and production of proinflammatory molecules as foreign bodies, M1 macrophages 
(similar to NK cells) responds through IFN-γ dan IL-12 secretions.
27,28
 By activating IFN-γ, M1 releases tumor 
recidual products including reactive oxygen intermediates and nitric oxides that destroy tumor cells.
29
 These 
activated macrophages also produces TNF-α, that also destroys foreign bodies by inhibiting vascular 
formation.
30
   
Macrophage alternative activation (M2) is a key step in the development of endometriosis, from which increased 
M2 macrophages secrete and increase concentrations of prostaglandin, complement components, and growth 
factors including TNF-α, IL-6, and TGF-β, IL-4, IL-13, IL-10, IL-1.
33,34
 Edometriosis cells entering the 
peritoneal cavity are normally eliminated by macrophages. This mechanism of aberration in endometriosis 
results in an ineffectve immunological cleaning system towards foreign bodies. M2 macrophages and increased 
cytokine levels induce the initiation of endometrial cellular prrogression, growth, and neovascularization.
33
 
Consequently, M2 macrophages tend to have a beneficial effect on cellular growth or tumors.     
M2 macrophages play a more significant role than M2 macrophages in the pathogenenesis of endometriosis. 
This may be due to genetic, hormonal, and enviromental factors. One study suggested that estrogen increases M2 
macrophage activities through estrogen receptors expressed by surface located macrophages. Under these effects 
of estrogen, M2 macrophages secrete cytokines and growth factors (including VEGF, hepatocyte growth factors, 
TNF-α), contributing to the developing and persistance nature of endometriosis.
35
  
This study indicated that CD68 and CD163 macrophages expressions significantly differed. In endometriosis 
lesions, CD 163 macrophages were apparently higer than CD 68 macrophages. CD 68 was also observed in 
eutopic endometrial women diagnosed with endometriosis with various levels in each menstrual phase. Increased 
CD68 macrophage cells was also present in eutopic endometrial women diagnosed with endmoteriosis during 
the proliferative phase, whereas CD162 was only observed in endometriosis lesions. Although observed in non-
endometriosis peritoneal specimens, immunohistochemical testing showed that CD68 also infiltrates 
endometriosis lesions.
13,15 
 
CONCLUSION 
L-selectin gene P213S polymorphism is associated with endometriosis. M2 Macrophage has a more significant 
role in developing endometriosis than M1 macrophage. 
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Figure Legends 
Figure 1. PCR electrophoresis of three genotypes. NB : L = Ladder 100 bp; Lane 10 PP genotype, visible band 
on 142 bp and 44 bp; lane 11 PS genotype visible band on 186 bp, 142 bp and 44 bp; lane 12 SS genotype 
visible band on 186 bp. 
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Figure 2. Expression of  CD163 
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Figure 3. Expression of CD68 
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